Richard S. Levy

2015

In 2015, Richard S. Levy earned a total compensation of $1.6M as Executive Vice President and Chief Drug Development Officer at Incyte, a 20% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$269,543
Option Awards$663,854
Salary$417,300
Stock Awards$221,241
Other$33,399
Total$1,605,337

Levy received $663.9K in option awards, accounting for 41% of the total pay in 2015.

Levy also received $269.5K in non-equity incentive plan, $417.3K in salary, $221.2K in stock awards and $33.4K in other compensation.

Rankings

In 2015, Richard S. Levy's compensation ranked 5,654th out of 13,638 executives tracked by ExecPay. In other words, Levy earned more than 58.5% of executives.

ClassificationRankingPercentile
All
5,654
out of 13,638
59th
Division
Services
976
out of 2,167
55th
Major group
Engineering, Accounting, Research, Management, And Related Services
68
out of 197
66th
Industry group
Research, Development, And Testing Services
20
out of 65
69th
Industry
Commercial Physical and Biological Research
18
out of 53
66th
Source: SEC filing on April 18, 2016.

Levy's colleagues

We found four more compensation records of executives who worked with Richard S. Levy at Incyte in 2015.

2015

Hervé Hoppenot

Incyte

Chief Executive Officer

2015

Reid Huber

Incyte

Chief Scientific Officer

2015

Wenqing Yao

Incyte

Executive Vice President, Head of Discovery Chemistry

2015

David Gryska

Incyte

Chief Financial Officer

You may also like